E
Edgar Ben-Josef
Researcher at University of Michigan
Publications - 86
Citations - 6699
Edgar Ben-Josef is an academic researcher from University of Michigan. The author has contributed to research in topics: Radiation therapy & Pancreatic cancer. The author has an hindex of 33, co-authored 79 publications receiving 6259 citations. Previous affiliations of Edgar Ben-Josef include Northwestern University & University of Texas MD Anderson Cancer Center.
Papers
More filters
Journal ArticleDOI
NCCN clinical practice guidelines in oncology: hepatobiliary cancers.
Al B. Benson,Thomas A. Abrams,Edgar Ben-Josef,P. Mark Bloomston,Jean F. Botha,Bryan M. Clary,Anne M. Covey,Steven A. Curley,Michael I. D'Angelica,Rene Davila,William D. Ensminger,John F. Gibbs,Daniel Laheru,Mokenge P. Malafa,Jorge Marrero,Steven G. Meranze,Sean J. Mulvihill,James O. Park,James A. Posey,Jasgit Sachdev,Riad Salem,Elin R. Sigurdson,Constantinos T. Sofocleous,Jean-Nicolas Vauthey,Alan P. Venook,Laura W. Goff,Yun Yen,Andrew X. Zhu +27 more
Journal ArticleDOI
Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Theodore S. Hong,Jennifer Y. Wo,Beow Y. Yeap,Edgar Ben-Josef,Erin McDonnell,Lawrence S. Blaszkowsky,Eunice L. Kwak,Jill N. Allen,Jeffrey W. Clark,Lipika Goyal,Janet E. Murphy,Milind Javle,John A. Wolfgang,Lorraine C. Drapek,Ronald S. Arellano,Harvey J. Mamon,John T. Mullen,Sam S. Yoon,Kenneth K. Tanabe,Cristina R. Ferrone,David P. Ryan,Thomas F. DeLaney,Christopher H. Crane,Andrew X. Zhu +23 more
TL;DR: High-dose hypofractionated proton therapy demonstrated high LC rates for H CC and ICC safely, supporting ongoing phase III trials of radiation in HCC and ICC.
Journal ArticleDOI
Phase II Trial of High-Dose Conformal Radiation Therapy With Concurrent Hepatic Artery Floxuridine for Unresectable Intrahepatic Malignancies
Edgar Ben-Josef,Daniel P. Normolle,William D. Ensminger,Suzette Walker,D. Tatro,Randall K. Ten Haken,James A. Knol,Laura A. Dawson,Charlie Pan,Theodore S. Lawrence +9 more
TL;DR: The results suggest that, compared with historical controls, high-dose focal liver irradiation with hepatic artery floxuridine prolongs survival in patients with unresectable chemotherapy-refractory metastatic colorectal cancer and primary hepatobiliary tumors.
Journal ArticleDOI
Pancreatic Adenocarcinoma, Version 2.2012 Featured Updates to the NCCN Guidelines
Margaret A. Tempero,J. Pablo Arnoletti,Stephen Behrman,Edgar Ben-Josef,Al B. Benson,Ephraim S. Casper,Steven J. Cohen,Brian G. Czito,Joshua D. I. Ellenhorn,William G. Hawkins,Joseph M. Herman,John P. Hoffman,Andrew H. Ko,Srinadh Komanduri,Albert C. Koong,Wen Wee Ma,Mokenge P. Malafa,Nipun B. Merchant,Sean J. Mulvihill,Peter Muscarella,Eric K. Nakakura,Jorge Obando,Martha B. Pitman,Aaron R. Sasson,Anitra Tally,Sarah P. Thayer,Samuel Whiting,Robert A. Wolff,Brian M. Wolpin,Deborah A. Freedman-Cass,Dorothy A. Shead +30 more
TL;DR: The panel made 3 significant updates to the guidelines: more detail was added regarding multiphase CT techniques for diagnosis and staging of pancreatic cancer, and pancreas protocol MRI was added as an emerging alternative to CT.
Journal ArticleDOI
Full-Dose Gemcitabine and Concurrent Radiotherapy for Unresectable Pancreatic Cancer
James D. Murphy,Saroja Adusumilli,Kent A. Griffith,Michael E. Ray,Mark M. Zalupski,Theodore S. Lawrence,Edgar Ben-Josef +6 more
TL;DR: In conjunction with full-dose gemcitabine, the use of conformal fields encompassing only the GTV helps reduce toxicity and does not result in marginal failures, providing rationale for intensification of local therapy in conjunction with more effective systemic therapy.